Pricing Log in Create free account

Embecta Corp. (EMBC) vs Anbio Biotechnology (NNNN)

Embecta Corp. and Anbio Biotechnology are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $474.8M against $365.5M — 1.3× the size. Across the 9 metrics below, Embecta Corp. leads on 5 and Anbio Biotechnology on 4.

Valuation

Metric EMBC NNNN Medical Instruments & Supplies median
P/E 4.21 — 33.75
P/S 0.36 — 2.52
P/B n/m n/m 2.48
Price to free cash flow 2.10 n/m 25.19
EV/EBITDA 5.67 n/m 14.62
EV/Sales 1.60 n/m 2.88
Earnings yield 23.76% — (2.67%)
Free cash flow yield 47.65% 0.00% 0.09%

Profitability

Metric EMBC NNNN Medical Instruments & Supplies median
Gross margin 59.03% — 54.29%
Operating margin 21.94% — 1.07%
Net margin 8.59% — (1.61%)
Free cash flow margin 17.15% 0.00% 1.08%
Return on equity (13.65%) 0.00% (1.32%)
Return on assets 7.22% 0.00% 0.00%
Return on invested capital 21.44% 0.00% 0.00%

Growth

Metric EMBC NNNN Medical Instruments & Supplies median
Revenue growth (TTM) (7.60%) — 8.85%
EPS growth (last fiscal year) 20.90% 150.00% 8.65%
Revenue growth, 5-year CAGR (1.50%) — 9.17%
Net income growth, 5-year CAGR (25.47%) — 0.00%

Health

Metric EMBC NNNN Medical Instruments & Supplies median
Debt to equity (2.42) 0.00 0.10
Current ratio 1.68 344.45 2.48
Net debt to EBITDA 3.96 (2.06) 0.89

Dividend

Metric EMBC NNNN Medical Instruments & Supplies median
Dividend yield 5.10% — 1.11%
Payout ratio 0.22 — 0.27

Size

Metric EMBC NNNN Medical Instruments & Supplies median
Market cap 365.46m 474.84m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack